tiprankstipranks
Clarity Pharmaceuticals Ltd. (AU:CU6)
ASX:CU6
Australian Market

Clarity Pharmaceuticals Ltd. (CU6) Income Statement

38 Followers

Clarity Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2022), Clarity Pharmaceuticals Ltd.'s total revenue was AU$―. In Q4, Clarity Pharmaceuticals Ltd.'s net income was AU$―. See Clarity Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
AU$ 30.29M
Operating Income
AU$ -30.29M
Net Non Operating Interest Income Expense
AU$ 95.09K
Other Income Expense
AU$ 6.46M
Pretax Income
AU$ -23.74M
Tax Provision
AU$ 17.63K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
AU$ -23.75M
Basic EPS
AU$ -0.10
Diluted EPS
AU$ -0.10
Basic Average Shares
AU$ 247.70M
Diluted Average Shares
AU$ 247.70M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
-
Net Income From Continuing And Discontinued Operation
AU$ -23.75M
Normalized Income
AU$ -23.75M
Interest Expense
-
EBIT
AU$ -30.29M
EBITDA
AU$ -30.24M
Currency in AUD

Clarity Pharmaceuticals Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis